Page last updated: 2024-08-24

beta-lysylmethanediamine and Malaria

beta-lysylmethanediamine has been researched along with Malaria in 1 studies

*Malaria: A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ishiyama, A; Iwatsuki, M; Kondo, S; Namatame, M; Nishihara-Tukashima, A; Omura, S; Otoguro, K; Shibahara, S; Yamada, H1

Other Studies

1 other study(ies) available for beta-lysylmethanediamine and Malaria

ArticleYear
Promising lead compounds for novel antiprotozoals.
    The Journal of antibiotics, 2010, Volume: 63, Issue:7

    Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antimalarials; Antiprotozoal Agents; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; In Vitro Techniques; Lysine; Malaria; Pactamycin; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Trypanocidal Agents; Trypanosoma brucei brucei; Trypanosomiasis, African

2010